المؤلفون: Nagasaka, Misako, Li, Yiwei, Sukari, Ammar, Ou, Sai-Hong, Al-Hallak, Mohammed, Azmi, Asfar

مصطلحات موضوعية: AMG 510, ARS 3248, Kirsten rat sarcoma viral oncogene homolog, MRTX 849, Non-small cell lung cancer, Targeted therapy, Antineoplastic Agents, Humans, Molecular Targeted Therapy, Mutation, Neoplasms, Prognosis, Proto-Oncogene Proteins p21(ras)

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/6zv8n5f3

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

مصطلحات الفهرس: encorafenib/dt [Drug Therapy], erlotinib/dt [Drug Therapy], fluoropyrimidine/dt [Drug Therapy], fluorouracil/ae [Adverse Drug Reaction], fluorouracil/dt [Drug Therapy], folinic acid/ae [Adverse Drug Reaction], folinic acid/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], irinotecan/ae [Adverse Drug Reaction], irinotecan/dt [Drug Therapy], mitomycin/dt [Drug Therapy], oxaliplatin/ae [Adverse Drug Reaction], oxaliplatin/dt [Drug Therapy], panitumumab/dt [Drug Therapy], ramucirumab/dt [Drug Therapy], tipiracil plus trifluridine/ae [Adverse Drug Reaction], tipiracil plus trifluridine/dt [Drug Therapy], trametinib/dt [Drug Therapy], BRAF gene, HER2 gene, KRAS gene, NTRK gene, mrtx 849, vemurafenib/dt [Drug Therapy], cancer chemotherapy, diarrhea/si [Side Effect], evidence based medicine, febrile neutropenia/si [Side Effect], gene, gene amplification, gene expression, gene mutation, human, medical expert, medical specialist, metastatic colorectal cancer/dt [Drug Therapy], microbiome, mismatch repair, neutropenia/si [Side Effect], overall survival, review, signal transduction, aflibercept/dt [Drug Therapy], bevacizumab/dt [Drug Therapy], capecitabine/dt [Drug Therapy], cetuximab/dt [Drug Therapy], circulating tumor DNA/ec [Endogenous Compound], dabrafenib/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29281
Expert Review of Anticancer Therapy
Click here for full text options
LibKey Link

مصطلحات الفهرس: encorafenib/dt [Drug Therapy], erlotinib/dt [Drug Therapy], fluoropyrimidine/dt [Drug Therapy], fluorouracil/ae [Adverse Drug Reaction], fluorouracil/dt [Drug Therapy], folinic acid/ae [Adverse Drug Reaction], folinic acid/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], irinotecan/ae [Adverse Drug Reaction], irinotecan/dt [Drug Therapy], mitomycin/dt [Drug Therapy], oxaliplatin/ae [Adverse Drug Reaction], oxaliplatin/dt [Drug Therapy], panitumumab/dt [Drug Therapy], ramucirumab/dt [Drug Therapy], tipiracil plus trifluridine/ae [Adverse Drug Reaction], tipiracil plus trifluridine/dt [Drug Therapy], trametinib/dt [Drug Therapy], BRAF gene, HER2 gene, KRAS gene, NTRK gene, mrtx 849, vemurafenib/dt [Drug Therapy], cancer chemotherapy, diarrhea/si [Side Effect], evidence based medicine, febrile neutropenia/si [Side Effect], gene, gene amplification, gene expression, gene mutation, human, medical expert, medical specialist, metastatic colorectal cancer/dt [Drug Therapy], microbiome, mismatch repair, neutropenia/si [Side Effect], overall survival, review, signal transduction, aflibercept/dt [Drug Therapy], bevacizumab/dt [Drug Therapy], capecitabine/dt [Drug Therapy], cetuximab/dt [Drug Therapy], circulating tumor DNA/ec [Endogenous Compound], dabrafenib/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29281
Expert Review of Anticancer Therapy
LibKey Link